EDSA
insider transactionsEdesa Biotech, Inc. — buys & sells by directors, officers and 10% owners A shareholder owning more than 10% of the company. Must report trades, but usually a weaker signal than an officer or director. (SEC Form 4).
No open-market buys or sells this period. The trades below are grants, option exercises and gifts, which carry no market price.
Net buy / sell volume
Not enough data to chart yet.
Tap or hover the chart for daily net volume. Green = net buying, red = net selling.
All transactions
-
Grant·A
Pardeep Nijhawan KEY
Chief Executive Officer
$800.0K
153.6K sh · $5.21
Own +21%
-
Grant·A
Pardeep Nijhawan KEY
Chief Executive Officer
$0
1.7K sh
Own +0%
-
Grant·A
Director
$0
19.0K sh
Own +36%
-
Grant·A
Director
$0
19.0K sh
Own +86%
-
Grant·A
Peter J. Weiler KEY
Chief Financial Officer
$0
64.6K sh
Own +99%
-
Grant·A
Director
$0
19.0K sh
Own +62%
-
Grant·A
Director
$0
19.0K sh
Own +173%
-
Grant·A
Pardeep Nijhawan KEY
Chief Executive Officer
$0
96.9K sh
Own +15%
-
Grant·A
Director
$0
19.0K sh
Own +345%
-
Grant·A
Director
$0
19.0K sh
Own +172%
-
Grant·A
Michael J Brooks KEY
President
$0
64.6K sh
Own +28%
-
Grant·A
Pardeep Nijhawan KEY
Chief Executive Officer
$0
1.2K sh
Own +0%
-
Grant·A
Pardeep Nijhawan KEY
Chief Executive Officer
$0
2.6K sh
Own +0%
| Date▾ | Insider | Type | Shares | Value |
|---|---|---|---|---|
| Jun 16, 2026 | Pardeep Nijhawan KEY | Grant A | 153.6K | $800.0K |
| Jun 1, 2026 | Pardeep Nijhawan KEY | Grant A | 1.7K | $0 |
| May 27, 2026 | Marshall Patrick | Grant A | 19.0K | $0 |
| May 27, 2026 | Sean Arthur Macdonald | Grant A | 19.0K | $0 |
| May 27, 2026 | Peter J. Weiler KEY | Grant A | 64.6K | $0 |
| May 27, 2026 | Carlo Sistilli | Grant A | 19.0K | $0 |
| May 27, 2026 | Charles V Olson | Grant A | 19.0K | $0 |
| May 27, 2026 | Pardeep Nijhawan KEY | Grant A | 96.9K | $0 |
| May 27, 2026 | Da David Liu | Grant A | 19.0K | $0 |
| May 27, 2026 | Joan Chypyha | Grant A | 19.0K | $0 |
| May 27, 2026 | Michael J Brooks KEY | Grant A | 64.6K | $0 |
| May 1, 2026 | Pardeep Nijhawan KEY | Grant A | 1.2K | $0 |
| Apr 1, 2026 | Pardeep Nijhawan KEY | Grant A | 2.6K | $0 |
About EDSA insider trading
This page tracks insider transactions for Edesa Biotech, Inc. (EDSA) reported to the U.S. Securities and Exchange Commission on Form 4. Corporate insiders — directors, executive officers and beneficial owners of more than 10% of the stock — must disclose their trades within two business days. Open-market purchases (code P) and sales (code S) made at the insider's discretion are the most-watched opportunistic signals, while awards (A), option exercises (M) and tax-withholding (F) reflect compensation rather than conviction. Trades marked 10b5-1 were made under a pre-arranged plan and are considered routine. A cluster buy — several insiders buying within a short window — is historically a stronger bullish indicator than any single trade.